Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID ▲ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 7DZ8 | A8IL32 | State transition supercomplex PSI-LHCI-LHCII from the LhcbM1 lacking mutant of Chlamydomonas reinhardtii | |
| 7DZ8 | A8JCL6 | State transition supercomplex PSI-LHCI-LHCII from the LhcbM1 lacking mutant of Chlamydomonas reinhardtii | |
| 7DZ8 | Q93WL4 | State transition supercomplex PSI-LHCI-LHCII from the LhcbM1 lacking mutant of Chlamydomonas reinhardtii | |
| 7DZ8 | Q9ZSJ4 | State transition supercomplex PSI-LHCI-LHCII from the LhcbM1 lacking mutant of Chlamydomonas reinhardtii | |
| 7DZ8 | Q93WE0 | State transition supercomplex PSI-LHCI-LHCII from the LhcbM1 lacking mutant of Chlamydomonas reinhardtii | |
| 7E17 | Q03405 | Structure of dimeric uPAR | |
| 7E1Z | P05023 | Cryo EM structure of a Na+-bound Na+,K+-ATPase in the E1 state | |
| 7E1Z | P05026 | Cryo EM structure of a Na+-bound Na+,K+-ATPase in the E1 state | |
| 7E1Z | P54710 | Cryo EM structure of a Na+-bound Na+,K+-ATPase in the E1 state | |
| 7E20 | P05023 | Cryo EM structure of a K+-bound Na+,K+-ATPase in the E2 state | |
| 7E20 | P05026 | Cryo EM structure of a K+-bound Na+,K+-ATPase in the E2 state | |
| 7E20 | P54710 | Cryo EM structure of a K+-bound Na+,K+-ATPase in the E2 state | |
| 7E21 | P05023 | Cryo EM structure of a Na+-bound Na+,K+-ATPase in the E1 state with ATP-gamma-S | |
| 7E21 | P05026 | Cryo EM structure of a Na+-bound Na+,K+-ATPase in the E1 state with ATP-gamma-S | |
| 7E21 | P54710 | Cryo EM structure of a Na+-bound Na+,K+-ATPase in the E1 state with ATP-gamma-S | |
| 7E23 | P0DTC2 | SARS-CoV-2 spike in complex with the CA521 neutralizing antibody Fab (focused refinement on Fab-RBD) | Spike protein S1, CA521 Heavy Chain, CA521 Light Chain |
| 7E23 | 7E23 | SARS-CoV-2 spike in complex with the CA521 neutralizing antibody Fab (focused refinement on Fab-RBD) | Spike protein S1, CA521 Heavy Chain, CA521 Light Chain |
| 7E29 | P0AEX9 | Crystal Structure of Saccharomyces cerevisiae Ioc4 PWWP domain fused with MBP | |
| 7E29 | Q04213 | Crystal Structure of Saccharomyces cerevisiae Ioc4 PWWP domain fused with MBP | |
| 7E2G | Q96F81 | Cryo-EM structure of hDisp1NNN-3C | |
| 7E2H | Q96F81 | Cryo-EM structure of hDisp1NNN-3C-Cleavage | |
| 7E2I | Q96F81 | Cryo-EM structure of hDisp1NNN-ShhN | |
| 7E2I | Q15465 | Cryo-EM structure of hDisp1NNN-ShhN | |
| 7E2V | 7E2V | Crystal structure of MaDA-3 | |
| 7E39 | P0DTC2 | SARS-CoV-2 spike in complex with the Ab4 neutralizing antibody (State 3) | |
| 7E39 | 7E39 | SARS-CoV-2 spike in complex with the Ab4 neutralizing antibody (State 3) | |
| 7E3B | P0DTC2 | SARS-Cov-2 spike in complex with the Ab5 neutralizing antibody (focused refinement on Fab-RBD) | |
| 7E3B | 7E3B | SARS-Cov-2 spike in complex with the Ab5 neutralizing antibody (focused refinement on Fab-RBD) | |
| 7E3C | P0DTC2 | SARS-CoV-2 spike in complex with the Ab1 neutralizing antibody (focused refinement on Fab-RBD) | |
| 7E3C | 7E3C | SARS-CoV-2 spike in complex with the Ab1 neutralizing antibody (focused refinement on Fab-RBD) | |
| 7E3D | P22303 | Crystal structure of human acetylcholinesterase | |
| 7E3E | D6XHE1 | Crystal structure of Trypanosoma brucei cathepsin B R91C/T223C mutant | |
| 7E3F | D6XHE1 | Crystal structure of Trypanosoma brucei cathepsin B Y217C/S275C mutant | |
| 7E3G | D6XHE1 | Crystal structure of Trypanosoma brucei cathepsin B R91C/T223C mutant in the living cell | |
| 7E3H | P22303 | Crystal structure of human acetylcholinesterase in complex with donepezil | |
| 7E3J | 7E3J | Crystal structure of SARS-CoV-2 RBD binding to dog ACE2 | |
| 7E3J | P0DTC2 | Crystal structure of SARS-CoV-2 RBD binding to dog ACE2 | |
| 7E3K | P0DTC2 | Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants | |
| 7E3K | 7E3K | Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants | |
| 7E3L | P0DTC2 | Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants | |
| 7E3L | 7E3L | Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants | |
| 7E57 | Q7TS55 | Crystal structure of murine GITR-GITRL complex | |
| 7E57 | O35714 | Crystal structure of murine GITR-GITRL complex | |
| 7E5M | P09758 | crystal structure of trans assembled human TROP-2 | |
| 7E5O | P0DTC2 | Crystal structure of SARS-CoV-2 RBD in complex with antibody NT-193 | |
| 7E5O | 7E5O | Crystal structure of SARS-CoV-2 RBD in complex with antibody NT-193 | |
| 7E5R | P0DTC2 | SARS-CoV-2 S trimer with three-antibody cocktail complex | |
| 7E5R | 7E5R | SARS-CoV-2 S trimer with three-antibody cocktail complex | |
| 7E5S | P0DTC2 | SARS-CoV-2 S trimer with four-antibody cocktail complex | |
| 7E5S | 7E5S | SARS-CoV-2 S trimer with four-antibody cocktail complex |
